论文部分内容阅读
目的:分析急性心肌梗死患者实施冠状动脉介入治疗以后,应用不同剂量的阿托伐他汀对于患者早期血脂与近期的心血管事件影响。方法:选在韶关市第一人民医院2016年1月至2017年7月行冠状动脉介入治疗的急性心肌梗死患者35例,依据治疗后的用药方式区别划分成中强度组与高强度组,中强度组患者17例,高强度组患者18例,观察治疗的效果。结果:治疗后,高强度组低密度脂蛋白胆固醇(LDL-C)以及总胆固醇指标与中强度组相比,数值明显要比中强度组小,组间比较,差异具有统计学意义(P<0.05)。结论:急性心肌梗死患者实施冠状动脉介入治疗以后,采取40 mg·d~(-1)阿托伐他汀治疗,能降低患者心血管事件的发生率。
OBJECTIVE: To analyze the effect of different doses of atorvastatin on early lipid profile and recent cardiovascular events in patients with acute myocardial infarction after coronary intervention. Methods: Thirty-five patients with acute myocardial infarction undergoing coronary intervention from January 2016 to July 2017 in Shaoguan First People’s Hospital were divided into moderate-intensity group and high-intensity group according to the way of treatment after treatment 17 patients in intensity group and 18 patients in high intensity group. The effect of treatment was observed. Results: After treatment, the levels of LDL-C and total cholesterol in the high-intensity group were significantly lower than those in the middle-intensity group, and the difference was statistically significant (P < 0.05). Conclusion: Atrovastatin 40 mg · d -1 can reduce the incidence of cardiovascular events in patients with acute myocardial infarction after coronary intervention.